<SEC-DOCUMENT>0001104659-12-027825.txt : 20120524
<SEC-HEADER>0001104659-12-027825.hdr.sgml : 20120524
<ACCEPTANCE-DATETIME>20120424173030
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-12-027825
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20120424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>


<html>
<head>


  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="58%" valign="top" style="padding:0in 0in 0in 0in;width:58.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="3" face="Times New Roman" style="font-weight:bold;"><img width="214" height="35" src="g101245bci001.jpg"></font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">&nbsp;<br><br></font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Merav   Gershtenman </font></b><font size="2" style="font-size:10.0pt;">| 212 692 6806 | mgershtenman@mintz.com</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chrysler Center<br>   666 Third Avenue<br>   New York, NY 10017<br> 212-935-3000<br>   212-983-3115 fax<br> www.mintz.com</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">April&nbsp;24, 2012</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Via EDGAR and by Federal Express</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Securities and Exchange Commission<br> Division of Corporation Finance<br> 100 F Street, N.E.<br> Mail Stop 3561<br> Washington, D.C. 20549</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Re:</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Cyclacel Pharmaceuticals,&nbsp;Inc.</font></b></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Post-Effective Amendment No.&nbsp;1 to Form&nbsp;S-3 on Form&nbsp;S-1</font></b></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Filed on April&nbsp;4, 2012</font></b></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">File No.&nbsp;333-140034</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentleman:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On behalf of Cyclacel Pharmaceuticals,&nbsp;Inc. (the &#147;<b>Company</b>&#148;), we hereby file with the Securities and Exchange Commission (the <b>&#147;Commission&#148;</b>) a Post-Effective Amendment No.&nbsp;2 to Form&nbsp;S-3 on Form&nbsp;S-1 (File No.&nbsp;333-140034) as initially filed with the Commission on April&nbsp;4, 2012 (the &#147;<b>Post-Effective Amendment</b>&#148;).&#160; We are also delivering two clean courtesy copies of the Amendment to the attention of Karen Ubell,&nbsp;Esq. of the Commission.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Set forth below is the Company&#146;s response to the comments provided by the staff (the &#147;<b>Staff</b>&#148;) of the Commission by way of a letter (the &#147;<b>Comment Letter</b>&#148;) dated April&nbsp;11, 2012, from Jeffrey Riedler,&nbsp;Esq., Assistant Director of the Division of Corporation Finance.&#160; The Company&#146;s responses are numbered to correspond to the comments, as set forth in the Comment Letter, which, for convenience, we have incorporated into this response letter.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Incorporation by Reference, page&nbsp;50</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">We note that your registration statement incorporates by reference materials from your Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2011. This filing does not contain the information required by Part&nbsp;III of Form&nbsp;10-K. We will not be in a position to accelerate the effectiveness of your registration statement until you amend your Form&nbsp;10-K to include the Part&nbsp;III information or have provided the information in a definitive proxy statement.</font></b></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><i><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Response</font></u></i><font size="2" style="font-size:10.0pt;">:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In response to the Staff&#146;s comment, the Company incorporated by reference the definitive proxy statement filed with the Securities and Exchange Commission on April&nbsp;19, 2012, which contains the information required by Part&nbsp;III of Form&nbsp;10-K.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BOSTON | WASHINGTON | NEW YORK | STAMFORD | LOS ANGELES | PALO ALTO | SAN DIEGO | LONDON</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C901044\12-10124-5\task5286637\10124-5-bc.htm',USER='C901044',CD='Apr 23 23:39 2012' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">You have included language incorporating by reference reports and documents you subsequently file pursuant to Section&nbsp;13(a), 13(c), 14 and 15(d)&nbsp;of the Securities Exchange Act or Exchange Act after the date of the prospectus. Forward incorporation is not permissible for registration statement on Form&nbsp;S-1. Please amend your filing to delete this paragraph.</font></b></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><i><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Response</font></u></i><font size="2" style="font-size:10.0pt;">:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In response to the Staff&#146;s comment, the Company deleted the paragraph that referenced future incorporation of reports and documents by reference.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company hereby acknowledges that:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">the Company is responsible for the adequacy and accuracy of the disclosure in its filings;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Staff comments or changes to disclosure to Staff comments do not foreclose the Commission from taking any action with respect to the filings; and</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please call Avisheh Avini at (212) 692-6200 or the undersigned at (212) 692-6806 with any comments or questions and please send a copy of any written comments to the following parties:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr style="page-break-inside:avoid;">
<td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="73%" valign="top" style="padding:0in 0in 0in 0in;width:73.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Avisheh Avini,&nbsp;Esq.</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="73%" valign="top" style="padding:0in 0in 0in 0in;width:73.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Merav Gershtenman,&nbsp;Esq.</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="73%" valign="top" style="padding:0in 0in 0in 0in;width:73.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mintz,   Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="73%" valign="top" style="padding:0in 0in 0in 0in;width:73.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">666   Third Avenue</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="73%" valign="top" style="padding:0in 0in 0in 0in;width:73.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">New   York, NY 10017</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="73%" valign="top" style="padding:0in 0in 0in 0in;width:73.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phone:   (212) 935-3000</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="73%" valign="top" style="padding:0in 0in 0in 0in;width:73.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fax:   (212) 983-3115</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.86%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very   truly yours,</font></p>    </td>   </tr>
<tr>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.86%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.86%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:1.0pt;font-style:italic;">&nbsp;</font></i></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.14%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">/s/ Merav   Gershtenman</font></i></p>    </td>   </tr>
<tr>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.86%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:50.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Merav   Gershtenman</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="93%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:93.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">cc:</font></p>    </td>
<td width="93%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:93.34%;">
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Securities   and Exchange Commission</font></u><font size="2" style="font-size:10.0pt;"> (Jeffrey Riedler,&nbsp;Esq., Assistant   Director) </font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="93%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:93.34%;">
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cyclacel   Pharmaceuticals,&nbsp;Inc.</font></u><font size="2" style="font-size:10.0pt;"> (Spiro Rombotis,   President and Chief Executive Officer; &nbsp;Paul McBarron, Chief Operating Officer,   Chief Financial Officer and Executive Vice President, Finance)</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2<a name="PB_2_095743_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\C901044\12-10124-5\task5286637\10124-5-bc.htm',USER='C901044',CD='Apr 23 23:39 2012' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g101245bci001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g101245bci001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MP``+"``C`-8!`1$`_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+
M_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$(
M(T*QP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%56
M5UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI
MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W
M^/GZ_]H`"`$!```_`/=[ZZ:RLI;A+6>Z9!D0P`%W^F2!^M<SX8^(NC^*M<O=
M&M;:_M;^R0M-#>0B,KA@I'#'D$BNNK*\1^(+'PMH-UK.I%Q:VX!81@%CD@``
M$C)R15+PMXN@\6VJWEEI>IV]FZ;X[B[B5$DYQ\N&)/Y8XKHJ***175U#(P93
MT(.12TTNH."P!XXSZ]*=13)7,<+R+&TA520B8RV.PSQFN#F^+.F0>(4T"70]
M>75I,;+7[,A9@1G(^?&,`G.>QKNK:9KBUBF:"2!G4,8I<;D]C@D9^AJ6BBBB
MBBBBBBOG'4GN?"7C6?XBV^][4>(+JPOXU_YY9`'_`+-^(6OHJWN(KJVBN()%
MDAE0/&ZG(92,@C\*\;^,EQ-XCM-7TRWD9=.T"U%W>,IXDN7P(H_P4LY^HKL_
M`%E:ZM\)=!M+N+S+>2QC#IN*YQ[@@]17&?"#2+:]UGQ3+>/=7+:=J+6UIYUS
M(XBC!<8`+>GKZ50\36VL^"/B-<:KX52XFTS3K&*YOM.:X=U:-V=7VAB<8V`^
MW7ID5[#H.NZ9XLT"'4M.F$UI<H01T93W5AV(KA=,\)6EO\4M9BMA-Y-I86]S
M902W4K113,7&[;NYY0?K6UHGPQT+2])AM[G[5=W6W=/.;R9`\AY8A58!1G/`
M%<9\'=#LO$GAO4[G6&O+N:'4Y8(W>]F!5`J$#AQZFNBF^%BM+?VD&H31Z3?7
MMO/*IGD>81Q*Q\M7))`,A!SG@9]JO:[X=\&^%]`N=5U"&YCM;6/)S?SEF/0*
M/GY).`*P?A-X7O9GE\8:NUU#]L9FT[3WN)'2VA;H2&)R2.F>W/?CU>O&=5_Y
M.DT;_L''_P!%RU[-7DGQYM4M/"D.M6LEQ;ZBMU%`)X9W0E"&RI`.*ZRX\!^&
M#IK&X6Y@1D`:;^T9U*Y[Y+XZUPOQ`\"7VF?#.*_MKZZ?6-*C7[3-#<R`7,"G
M!W#/4+M.?8UZ=X/O+#4?"&EWFF)Y=G-;JZ1[BVPGJN22>#D?A7(7OAZR\5_%
M2X`$ZV&EVZ_;_*N)$6YN'`*1L`V,*@#'']X`U@?%W1K73]7\*M9-<VIO]12U
MNA#<R*)8_D&#AO3N*Z/XE>%M,MOA[?W-DL]I<Z?;DVLL-S(I3YLD'YN0<GKG
MK5;X=>,+ZSOF\">+3Y6NV2XMIV;*WL0Z$,>IP/Q`]0:O?%W1X+CP3?ZK&\\&
MHVB)Y-Q#,Z%1YB@C`(!X)ZUV6CZ39Z)IT=E8QLD*\X:1G))ZDEB2:OUYGX5T
M2U\7?#C7].N<&+4=3OB&Q]QC,Q5A]"`?PKG/AQX]?PWX-UK0-;4MJWAYS%;V
MY/S3@MM2-?7YR%^C+6YXFT&70?@;KT=XPDU.ZB-W?S#_`):3NZEOP'"CV45T
M7PJ??\+O#Q_Z=0/R)%<O\%_^0IXY_P"PR_\`-JZFS*GXM:Q&><Z-:G!'4>;+
M7%Z[I=_\(_$,OBCP_`\_A>\<?VIIJ?\`+N2?]8@[#^73H1CJ?#&K6.N_$'5=
M3TVX2XM+C2;-HY%/^W-P?0CN.U=V>AKRCX!?\BCK'_88F_\`0$KU8D*"20`.
M237CQ+?&'QUL&6\&:%-\W]V^N!_-1_+_`'N/80`JA5```P`.U+7C.J_\G2:-
M_P!@X_\`HN6O9J\I^/[J_P`-U"N#C48E.#G!PU:NN>!-5OM%1+;Q1J]VZR0R
M&VNY(O*F"NK%6VH#T![]:[VX@BNK:6WG0/%*A1T/1E(P1^5>-^`M?3X??\);
MX3U5V*:*7O;('[TL+=%7W)*?BYKTCP9H\^C^'8Q?8.I7;M>7S>L\AW,/H.%'
MLHKAOC1_R%/`W_893^:UUGQ.('PUUXDX_P!&/\Q4?CSP);>--(A:*3[)K-GB
M2QO4X:-QS@D<[21^'45Y_J'CR?5_AUX@\->)(Q9^*-/C1)HGP!<*)$_>)V/'
M)`^HX/'N"_='TJCK$FK1V!.BV]G->$X"W<S1H!@\Y56)YQQQ]:Y3X<^'O$OA
M/2QI&JKID]MYLDWVJWG??N<[L%"@'4GG/X5%>_#2TO/BU:>,6$?DQ0;I(>[W
M"\(__?//U45I?$#2-?\`$7AVZT31X]/6*]B\N:XNIW4QC(^ZJH<\>XJEX)T?
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MID$+F%5:4*=BLV`3V!.#@?A7D>I>!O'NH?$>V\:0RZ!:W-L@BCMC-+(I3!!#
M'8.NX_3BNON)_B*866WL/#(E*\.]Y.0I]<>7S^=<;KOPW\6ZQX'M_#?G:49G
MNS?WNH2W$A:6=BQ8!1'P/F`SGHHX%=K!+X]@LHHY-/\`#T\ZH%9Q>S(&('7'
ME'\LU:\):7K5DNHWWB&YMY=2OKCS"EJS&&&-5"HB;@#QR2<<DUB^)_AW%X@^
M(OA[Q&1&(;(-]K0GF3:=T7'?#9S[`5WM>;?$'PEXI\6ZMI,M@NDP6NDW0NHC
M/<2%YV!4@$!,*./4UJ^,])\3>*/!DNC6]MIEM<7L>RYD>Z=EAPP(VXCRV0.^
M,9[UT6B'5O[/1-8M[2*Y0!?]%F:17``Y^95(YSQS]:Y'XF?#2V\;VD-Y:^7!
LK5H089FX$J@Y*/[>A['ZFN_`PH'M2T44444444444444444444444445_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
